Antipsychotic Discontinuation in Alzheimer's Disease

NCT00417482 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease
Psychotic Disorders
Agitation
Aggression

Interventions

DRUG: risperidone

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]
[object Object]